Since this not a mandatory tender, you don't have to do anything. Or if you like the offer, you can then accept. If a majority of share holders accepts the offer, it would become final.
If this is indeed DNA, Roche is making a hostile offer to share holders directly. Most people seem to think the offer is too low, if you agree, you should reject the offer.